Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML
Clinical trial NCT03654703 · UNKNOWN
Trial details
- NCT number
- NCT03654703
- Sponsor
- Capital Research Institute of Pediatrics
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2018-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.